Under the microscope: SomnoMed (ASX:SOM) - Neil Verdal-Austin, Chief Executive Officer

from Morgans Under the Microscope · host Morgans Financial Limited

SomnoMed (ASX:SOM) Chief Executive Officer Neil Verdal-Austin, joins Morgans Research Analyst Iain Wilkie to discuss the company's 1H20 results, and share some insight into what to expect in the next 12 months.

Episode metadata supplied by the publisher feed · Published Mar 6, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Under the microscope: SomnoMed (ASX:SOM) - Neil Verdal-Austin, Chief Executive Officer

0:00 10:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Under the Microscope?

This episode is 10 minutes long.

When was this Morgans Under the Microscope episode published?

This episode was published on March 6, 2020.

Can I download this Morgans Under the Microscope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!